Animal models for HIV AIDS: A comparative review

Comparative Medicine

Volumn 57, Issue 1, 2007, Pages 33-43

  Stump, Debora S ^a   VandeWoude, Sue ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; BABOON; BOVINE IMMUNODEFICIENCY LIKE VIRUS; CAPRINE ARTHRITIS ENCEPHALITIS VIRUS; CATTLE; CHIMPANZEE; COMPARATIVE STUDY; EQUINE INFECTIOUS ANEMIA VIRUS; EXPERIMENTAL CAT; EXPERIMENTAL MOUSE; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; GOAT; HORSE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENTIVIRINAE; MACACA; MURINE LEUKEMIA VIRUS; NONHUMAN; REVIEW; SHEEP; SIMIAN IMMUNODEFICIENCY VIRUS; VISNA VIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; DISEASE MODELS, ANIMAL; LENTIVIRUS; LENTIVIRUS INFECTIONS; PHYLOGENY; SPECIES SPECIFICITY;

EID: 33847289763     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (145)

1. Akkina R, Banerjea A, Bai J, Anderson J, Li MJ, Rossi J. 2003. Sirnas, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS. Anticancer Res 23(3A):1997-2005.
2. Allison RW, Hoover EA. 2003. Feline immunodeficiency virus is concentrated in milk early in lactation. AIDS Res Hum Retroviruses 19(3):245-253.
3. Amedee AM, Rychert J, Lacour N, Fresh L, Ratterree M. 2004. Viral and immunological factors associated with breast milk transmission of SIV in rhesus macaques. Retrovirology 1(1):1-17.
4. Apetrei C, Kaur A, Lerche NW, Metzger M, Pandrea I, Hardcastle J, Falkenstein S, Bohm R, Koehler J, Traina-Dorge V, Williams T, Staprans S, Plauche G, Veazey RS, McClure H, Lackner AA, Gormus B, Robertson DL, Marx PA. 2005. Molecular epidemiology of simian immunodeficiency virus SIVSM in US primate centers unravels the origin of SIVmac and sivstm. J Virol 79(14):8991-9005.
5. Apetrei C, Lerche NW, Pandrea I, Gormus B, Silvestri G, Kaur A, Robertson DL, Hardcastle J, Lackner AA, Marx PA. 2006. Kuru experiments triggered the emergence of pathogenic SIVmac. AIDS 20(3):317-321.
6. Apetrei C, Robertson DL, Marx PA. 2004. The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa. Front Biosci 9:225-254.
7. Baliga RS, Chaves AA, Jing L, Ayers LW, Bauer JA. 2005. AIDS-related vasculopathy: evidence for oxidative and inflammatory pathways in murine and human AIDS. Am J Physiol Heart Circ Physiol 289(4):H1373-1380.
8. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220(4599):868-871.
9. Beischel J, Larson DF, Yu Q, Yang B, Sepulveda RT, Kelley T, Watson RR. 2004. Dilated cardiomyopathy in retrovirally infected mice: a novel model for silent viral DCM? Cardiovasc Toxicol 4(4):317-325.
10. Berkowitz RD, Alexanders, McCune JM. 2000. Causal relationships between HIV-1 coreceptor utilization, tropism, and pathogenesis in human thymus. AIDS Res Hum Retroviruses 16(11):1039-1045.
11. Biek R, Rodrigo AG, Holley D, Drummond A, Anderson CR Jr, Ross HA, Poss M. 2003. Epidemiology, genetic diversity, and evolution of endemic feline immunodeficiency virus in a population of wild cougars. J Virol 77(17):9578-9589.
12. Biek R, Ruth TK, Murphy KM, Anderson CR, Johnson M, DeSimone R, Gray R, Hornocker MG, Gillin CM, Poss M. 2006. Factors associated with microparasite seroprevalence and exposure risk in rocky mountain cougars. Journal of Wildlife Disease. Forthcoming.
13. Bontrop RE, Watkins DI. 2005. MHC polymorphism: AIDS susceptibility in non-human primates. Trends Immunol 26(4):227-233.
14. Brooks DG, Kitchen SG, Kitchen CM, Scripture-Adams DD, Zack JA. 2001. Generation of HIV latency during thymopoiesis. Nat Med 7(4):459-464.
15. Broussard SR, Staprans SI, White R, Whitehead EM, Feinberg MB, Allan JS. 2001. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J Virol 75(5):2262-2275.
16. Brown EW, Yuhki N, Packer C, O'Brien SJ. 1994. A lion lentivirus related to feline immunodeficiency virus: epidemiologic and phylogenetic aspects. J Virol 68(9):5953-5968.
17. Burkhard MJ, Dean GA. 2003. Transmission and immunopathogenesis of FIV in cats as a model for HIV Curr HIV Res 1(1):15-29.
18. Campbell RS, Robinson WF. 1998. The comparative pathology of the lentiviruses. J Comp Pathol 119(4):333-395.
19. Charman HP, Bladen S, Gilden RV, Coggins L. 1976. Equine infectious anemia virus: evidence favoring classification as a retravirus. J Virol 19(3):1073-1079.
20. Chaves AA, Baliga RS, Mihm MJ, Schanbacher BL, Basuray A, Liu C, Cook AC, Ayers LW, Bauer JA. 2006. Bacterial lipopolysaccharide enhances cardiac dysfunction but not retro viral replication in murine AIDS: roles of macrophage infiltration and toll-like receptor 4 expression. Am J Pathol 168(3):727-735.
21. Chaves AA, Mihm MJ, Schanbacher BL, Basuray A, Liu C, Ayers LW Bauer JA. 2003. Cardiomyopathy in a murine model of AIDS: evidence of reactive nitrogen species and corroboration in human HIV/AIDS cardiac tissues. Cardiovasc Res 60(1):108-118.
22. Chiu IM, Yaniv A, Dahlberg JE, Gazit A, Skuntz SF, Tronick SR, Aaronson SA. 1985. Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses. Nature 317(6035):366-368.
23. Chopra HC, Mason MM. 1970. A new virus in a spontaneous mammary tumor of a rhesus monkey. Cancer Res 30(8):2081-2086.
24. Clark S, Duggan J, Chakraborty J. 2001. TSL and LP-BM5: a comparison of two murine retrovirus models for HIV Viral Immunol 14(2):95-109.
25. Clements JE, Li M, Gama L, Bullock B, Carruth LM, Mankowski JL, Zink MC. 2005. The central nervous system is a viral reservoir in simian immunodeficiency virus-infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy. J Neurovirol 11(2):180-189.
26. Cohen J. 2000. AIDS research. Vaccine studies stymied by shortage of animals. Science 287(5455):959-960.
27. Cork LC, Hadlow WJ, Gorham JR, Piper RC, Crawford TB. 1974. Pathology of viral leukoencephalomyelitis of goats. Acta Neuropathol (Berl) 29(4):281-292.
28. Courchamp F, Suppo C, Fromont E, Bouloux C. 1997. Dynamics of two feline retroviruses (FIV and FeLV) within one population of cats. Proc Biol Sci 264(1383):785-794.
29. Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, Desrosiers RC. 1985. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228(4704):1201-1204.
30. de Parseval A, Chatterji U, Sun P, Elder JH. 2004. Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc Natl Acad Sci U S A 101(35):13044-13049.
31. de Parseval A, Grant CK, Sastry KJ, Elder JH. 2006. Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV env for CXCR4-dependent entry and reveals a cryptic neutralization epitope. J Virol 80(6):3088-3091.
32. de Rozieres S, Mathiason CK, Rolston MR, Chatterji U, Hoover EA, Elder JH. 2004. Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C. J Virol 78(17):8971-8982.
33. Dix RD, Cousins SW. 2004. Interleukin-2 immunotherapy and AIDS-related cytomegalovirus retinitis. Curr HIV Res 2(4):333-342.
34. Dix RD, Cousins SW. 2004. Susceptibility to murine cytomegalovirus retinitis during progression of MAIDS: correlation with intraocular levels of tumor necrosis factor-alpha and interferon-gamma. Curr Eye Res 29(2-3):173-180.
35. Dix RD, Cray C, Cousins SW. 1994. Mice immunosuppressed by murine retrovirus infection (MAIDS) are susceptible to cytomegalovirus retinitis. Curr Eye Res 13(8):587-595.
36. Donahue PR, Quackenbush SL, Gallo MV, deNoronha CM, Overbaugh J, Hoover EA, Mullins JI. 1991. Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol 65(8):4461-4469.
37. Dunham SP. 2006. Lessons from the cat: development of vaccines against lentiviruses. Vet Immunol Immunopathol 112(1-2):67-77.
38. Estaquier J, Idziorek T, de Bels F, Barre-Sinoussi F, Hurtrel B, Aubertin AM, Venet A, Mehtali M, Muchmore E, Michel P. 1994. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A 91(20):9431-9435.
39. Evermann JF. 1990. Comparative features of retroviral infections of livestock. Comp Immunol Microbiol Infect Dis 13(3):127-136.
40. Farzan M, Choe H, Martin K, Marcon L, Hofmann W, Karlsson G, Sun Y, Barrett P, Marchand N, Sullivan N, Gerard N, Gerard C, Sodroski J. 1997. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med 186(3):405-411.
41. Flaming KP, Frank DE, Carpenter S, Roth JA. 1997. Longitudinal studies of immune function in cattle experimentally infected with bovine immunodeficiency-like virus and/or bovine leukemia virus. Vet Immunol Immunopathol 56(1-2):27-38.
42. Frankel AD, Young JA. 1998. HIV-1: fifteen proteins and an RNA. Annu Rev Biochem 67:1-25.
43. Gardner MB. 1996. The history of simian AIDS. J Med Primatol 25(3):148-157.
44. Gardner MB. 2003. Simian AIDS: an historical perspective. J Med Primatol 32(4-5):180-186.
45. Germain K, Valas S. 2006. Distribution and heterogeneity of small ruminant lentivirus envelope subtypes in naturally infected french sheep. Virus Res 120(1-2):156-162.
46. Girard MP, Osmanov SK, Kieny MP. 2006. A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccine 24(19):4062-4081.
47. Goff SP. 2001. Retroviridae: the retroviruses and their replication. In: Knipe DM, Howley PW. Fields virology. 4th ed. Philadelphia (PA): Lippincott Williams and Wilkins. p 1871-1939.
48. Goldstein S, Ourmanov I, Brown CR, Beer BE, Elkins WR, Plishka R, Buckler-White A, Hirsch VM. 2000. Wide range of viral load in healthy African green monkeys naturally infected with simian immunodeficiency virus. J Virol 74(24):11744-11753.
49. Gonda MA, Braun MJ, Carter SG, Kost TA, Bess JW, Jr, Arthur LO, Van der Maaten MJ. 1987. Characterization and molecular cloning of a bovine lentivirus related to human immunodeficiency virus. Nature 330(6146):388- 391.
50. Goto Y, Nishimura Y, Baba K, Mizuno T, Endo Y, Masuda K, Ohno K, Tsujimoto H. 2002. Association of plasma viral RNA load with prognosis in cats naturally infected with feline immunodeficiency virus. J Virol 76(19):10079-10083.
51. Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ. 2006. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 12(3):289-295.
52. Gudnadottir M, Palsson PA. 1967. Transmission of maedi by inoculation of a virus grown in tissue culture from maedi-affected lungs. J Infect Dis 117(1):1-6.
53. Hamelin-Bourassa D, Skamene E, Gervais F. 1989. Susceptibility to a mouse acquired immunodeficiency syndrome is influenced by the H-2. Immunogenetics 30(4):266-272.
54. Harouse JM, Gettie A, Tan RC, Eshetu T, Ratterree M, Blanchard J, Cheng-Mayer C. 2001. Pathogenic determinants of the mucosally transmissible CXCR4-spedfic SHIV(SF33A2) map to env region. J Acquir Immune Defic Syndr 27(3):222-228.
55. Hartmann K. 1998. Feline immunodeficiency virus infection: an overview. Vet J 155(2):123-137.
56. Haynes BF, Montefiori DC. 2006. Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. Expert Rev Vaccines 5(3):347-363.
57. Heidecker G, Lerche NW, Lowenstine LJ, Lackner AA, Osborn KG, Gardner MB, Marx PA. 1987. Induction of simian acquired immune deficiency syndrome (SAIDS) with a molecular clone of a type D SAIDS retrovirus. J Virol 61(10):3066-3071.
58. Hoover EA, Mullins JI. 1991. Feline leukemia virus infection and diseases. J Am Vet Med Assoc 199(10):1287-1297.
59. Hu SL. 2005. Non-human primate models for AIDS vaccine research. Curr Drug Targets Infect Disord 5(2):193-201.
60. Huang M, Simard C, Jolicoeur P. 1992. Susceptibility of inbred strains of mice to murine AIDS (MAIDS) correlates with target cell expansion and high expression of defective MAIDS virus. J Virol 66(4):2398-2406.
61. Hyslop NS. 1966. Equine infectious anaemia (swamp fever): a review. Vet Rec 78(25):858-864.
62. Igarashi T, Shibata R, Hasebe F, Ami Y, Shinohara K, Komatsu T, Stahl-Hennig C, Petry H, Hunsmann G, Kuwata T, Hayami M. 1994. Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys. AIDS Res Hum Retroviruses 10(8):1021-1029.
63. Isaacson JA, Flaming KP, Roth JA. 1998. Effects of long-term infection with bovine immunodeficiency virus and/or bovine leukemia virus on antibody and lymphocyte proliferative responses in cattle. Vet Immunol Immunopathol 64(3):249-266.
64. Issel CJ, Coggins L. 1979. Equine infectious anemia: current knowledge. J Am Vet Med Assoc 174(7):727-733.
65. Joag SV, Adany I, Li Z, Foresman L, Pinson DM, Wang C, Stephens EB, Raghavan R, Narayan O. 1997. Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+T cells, and AIDS. J Virol 71(5):4016-4023.
66. Johnson PR, Goldstein S, London WT, Fomsgaard A, Hirsch VM. 1990. Molecular clones of SIVsm and SIVagm: experimental infection of macaques and African green monkeys. J Med Primatol 19(3-4):279-286.
67. Jolicoeur P. 1991. Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis. Faseb J 5(10):2398-2405.
68. Kanzaki LI, Looney DJ. 2004. Feline immunodeficiency virus: a concise review. Front Biosci 9:370-377.
69. Kaur A, Grant RM, Means RE, McClure H, Feinberg M, Johnson RP. 1998. Diverse host responses and outcomes following simian immunodeficiency virus SIVMAC239 infection in sooty mangabeys and rhesus macaques. J Virol 72(12):9597-9611.
70. Keele BF, Van Heuverswyn F, Li Y, Bailee E, Takehisa J, Santiago ML, Bibollet-Ruche F, Chen Y, Wain LV, Liegeois F, Loul S, Ngole EM, Bienvenue Y, Delaporte E, Brookfield JF, Sharp PM, Shaw GM, Peeters M, Hahn BH. 2006. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313(5786):523-526.
71. Kitchen SG, Killian S, Giorgi JV, Zack JA. 2000. Functional reconstitution of thymopoiesis after human immunodeficiency virus infection. J Virol 74(6):2943-2948.
72. Kohmoto M, Uetsuka K, Ikeda Y, Inoshima Y, Shimojima M, Sato E, Inada G, Toyosaki T, Miyazawa T, Doi K, Mikami T. 1998. Eight-year observation and comparative study of specific pathogen-free cats experimentally infected with feline immunodeficiency virus (FIV) subtypes A and B: terminal acquired immunodeficiency syndrome in a cat infected with FIV petaluma strain. J Vet Med Sci 60(3):315-321.
73. Kornfeld C, Ploquin MJ, Pandrea I, Faye A, Onanga R, Apetrei C, Poaty-Mavoungou V, Rouquet P, Estaquier J, Mortara L, Desoutter JF, Butor C, Le Grand R, Roques P, Simon F, Barre-Sinoussi F, Diop OM, Muller-Trutwin MC. 2005. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 115(4):1082-1091.
74. Lerche NW, Switzer WM, Yee JL, Shanmugam V, Rosenthal AN, Chapman LE, Folks TM, Heneine W. 2001. Evidence of infection with simian type d retrovirus in persons occupationally exposed to nonhuman primates. J Virol 75(4):1783-1789.
75. Leroux C, Cadore JL, Montelaro RC. 2004. Equine infectious anemia virus (EIAV): what has HIV's country cousin got to tell us? Vet Res 35(4):485-512.
76. Letvin NL, Li J, Halloran M, Cranage MP, Rud EW, Sodroski J. 1995. Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus. J Virol 69(7):4569-4571.
77. Levy JA. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57(1):183-289.
78. Levy JA, Kaminsky LS, Morrow WJ, Steimer K, Luciw P, Dina D, Hoxie J, Oshiro L. 1985. Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features. Ann Intern Med 103(5):694-699.
79. Li J, Lord CI, Haseltine W, Letvin NL, Sodroski J. 1992. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVMAC virus that expresses the HIV-1 envelope glycoproteins. J Acquir Immune Defic Syndr 5(7):639-646.
80. Li Q, Duan L, Estes JD, Ma ZM, Rourke T, Wang Y, Reilly C, Carlis J, Miller CJ, Haase AT. 2005. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434(7037):1148- 1152.
81. Liang B, Wang JY, Watson RR. 1996. Murine AIDS, a key to understanding retrovirus-induced immunodeficiency. Viral Immunol 9(4):225-239.
82. Loewen N, Poeschla EM. 2005. Lentiviral vectors. Adv Biochem Eng Biotechnol 99:169-191.
83. Lu TC, He JC, Klotman P. 2006. Animal models of HIV-associated nephropathy. Curr Opin Nephrol Hypertens 15(3):233-237.
84. Luciw PA, Pratt-Lowe E, Shaw KE, Levy JA, Cheng-Mayer C. 1995. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc Natl Acad Sci U S A 92(16):7490-7494.
85. McClure HM, Anderson DC, Fultz PN, Ansari AA, Lockwood E, Brodie A. 1989. Spectrum of disease in macaque monkeys chronically infected with SIV/smm. Vet Immunol Immunopathol 21(1):13-24.
86. McConnell I, Blacklaws BA, Bird P, Lee WC, Roy DJ, Sargan D. 1996. Lentivirus replication in lymphoid tissue: use of lymphatic cannulation to study the initial stages of infection and immunity. AIDS Res Hum Retroviruses 12(5):417-420.
87. McCune J, Kaneshima H, Krowka J, Namikawa R, Outzen H, Peault B, Rabin L, Shih CC, Yee E, Lieberman M. 1991. The SCID-HU mouse: a small animal model for HIV infection and pathogenesis. Annu Rev Immunol 9:399-429.
88. Miyazawa T. 2002. Infections of feline leukemia virus and feline immunodeficiency virus. Front Biosci 7:d504-518.
89. Montelaro RC, Grund C, Raabe M, Woodson B, Cook RF, Cook S, Issel CJ. 1996. Characterization of protective and enhancing immune responses to equine infectious anemia virus resulting from experimental vaccines. AIDS Res Hum Retroviruses 12(5):413-415.
90. Mullins JI, Chen CS, Hoover EA. 1986. Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. Nature 319(6051):333-336.
91. Murphey-Corb M, Martin LN, Rangan SR, Baskin GB, Gormus BJ, Wolf RH, Andes WA, West M, Montelaro RC. 1986. Isolation of an htlv-iii-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature 321(6068):435-437.
92. Narayan O, Kennedy-Stoskopf S, Zink MC. 1988. Lontivirus-host interactions: lessons from visna and caprine arthritis-encephalitis viruses. Ann Neurol 23 Suppl:S95-100.
93. NCBI [Internet]. Retroviruses complete genome: 2005 update [cited 19 Jan 2007]. Available at http://www.ncbi.nlm.nih.gov/Taxonomy/CommonTree/ wwwcmt.
94. Novembre FJ, Hirsch VM, McClure HM, Fultz PN, Johnson PR. 1992. SIV from stump-tailed macaques: molecular characterization of a highly transmissible primate lentivirus. Virology 186(2):783-787.
95. Onanga R, Kornfeld C, Pandrea I, Estaquier J, Souquiere S, Rouquet P, Mavoungou VP, Bourry O, M'Boup S, Barre-Sinoussi F, Simon F, Apetrei C, Roques P, Muller-Trutwin MC. 2002. High levels of viral replication contrast with only transient changes in CD4(+) and CD8(+) cell numbers during the early phase of experimental infection with simian immunodeficiency virus sivmnd-1 in mandrillus sphinx. J Virol 76(20):10256-10263.
96. Onuma M, Koomoto E, Furuyama H, Yasutomi Y, Taniyama H, Iwai H, Kawakami Y. 1992. Infection and dysfunction of monocytes induced by experimental inoculation of calves with bovine immunodeficiency-like virus. J Acquir Immune Defic Syndr 5(10):1009-1015.
97. Pandrea I, Apetrei C, Gordon S, Dufor J, Bohm R, Sumpter B, Roques P, Kaur A, Marx PA, Lackner AA, Veazey RS, Silvestri G. 2006. Paucity of CD4+CCR5+ T-cells is a feature of natural SIV hosts. Blood. Forthcoming.
98. Pandrea I, Onanga R, Rouquet P, Bourry O, Ngari P, Wickings EJ, Roques P, Apetrei C. 2001. Chronic SIV infection ultimately causes immunodeficiency in African non-human primates. AIDS 15(18):2461-2462.
99. Pardi D, Hoover EA, Quackenbush SL, Mullins JI, Callahan GN. 1991. Selective impairment of humoral immunity in feline leukemia virus-induced immunodeficiency. Vet Immunol Immunopathol 28(3-4):183-200.
100. Patel PH, Jacobo-Molina A, Ding J, Tantillo C, Clark AD, Jr., Raag R, Nanni RG, Hughes SH, Arnold E. 1995. Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase. Biochemistry 34(16):5351-5363.
101. Pedersen NC, Ho EW, Brown ML, Yamamoto JK. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235(4790):790-793.
102. Pisoni G, Quasso A, Moroni P. 2005. Phylogenetic analysis of small-ruminant lentivirus subtype b1 in mixed flocks: evidence for natural transmission from goats to sheep. Virology 339(2):147-152.
103. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. 1980. Detection and isolation of type c retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77(12):7415-7419.
104. Poss M, Ross HA, Painter SL, Holley DC, Terwee JA, Vandewoude S, Rodrigo A. 2006. Feline lentivirus evolution in cross-species infection reveals extensive G-to-A mutation and selection on key residues in the viral polymerase. J Virol 80(6):2728-2737.
105. Quackenbush SL, Donahue PR, Dean GA, Myles MH, Ackley CD, Cooper MD, Mullins JI, Hoover EA. 1990. Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FELV-FAIDS. J Virol 64(11)5465-5474.
106. Reimann KA, Li JT, Veazey R, Halloran M, Park IW, Karlsson GB, Sodroski J, Letvin NL. 1996. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J Virol 70(10):6922-6928.
107. Reimann KA, Li JT, Voss G, Lekutis C, Tenner-Racz K, Racz P, Lin W, Montefiori DC, Lee-Parritz DE, Lu Y, Collman RG, Sodroski J, Letvin NL. 1996. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J Virol 70(5):3198-3206.
108. Restrepo CS, Diethelm L, Lemos JA, Velasquez E, Ovella TA, Martinez S, Carrillo J, Lemos DF. 2006. Cardiovascular complications of human immunodeficiency virus infection. Radiographics 26(1):213-231.
109. Rey-Cuille MA, Berthier JL, Bomsel-Demontoy MC, Chaduc Y, Montagnier L, Hovanessian AG, Chakrabarti LA. 1998 Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol 72(5):3872-3886.
110. Roques P, Robertson DL, Souquiere S, Apetrei C, Nerrienet E, Barre-Sinoussi F, Muller-Trutwin M, Simon F. 2004. Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N. AIDS 18(10):1371-1381.
111. Ross MJ, Fan C, Ross MD, Chu TH, Shi Y, Kaufman L, Zhang W, Klotman ME, Klotman PE. 2006. HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells. J Acquir Immune Defic Syndr 42(1):1-11.
112. Rous P. 1979. A transmissible avian neoplasm, (sarcoma of the common fowl) by Peyton Rous, MD, experimental medicine for Sept 1, 1910, vol 12, p 696-705. J Exp Med 150(4):738-753.
113. Rovid AH, Carpenter S, Roth JA. 1995. Monocyte function in cattle experimentally infected with bovine immunodeficiency-like virus. Vet Immunol Immunopathol 45(1-2):31-43.
114. Rushlow K, Olsen K, Stiegler G, Payne SL, Montelaro RC, Issel CJ. 1986. Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus. Virology 155(2):309- 321.
115. Russell KE, Perkins PC, Hoffman MR, Miller RT, Walker KM, Fuller FJ, Sellon DC. 1999. Platelets from thrombocytopenic ponies acutely infected with equine infectious anemia virus are activated in vivo and hypofunctional. Virology 259(1):7-19.
116. Shelton GH, Grant CK, Cotter SM, Gardner MB, Hardy WD, Jr, DiGiacomo RF. 1990. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968-1988). J Acquir Immune Defic Syndr 3(6):623-630.
117. Silvestri G. 2005. Naturally SIV-infected sooty mangabeys: are we closer to understanding why they do not develop AIDS? J Med Primatol 34(5-6):243-252.
118. Silvestri G, Sodora DL, Koup RA, Paiardini M, O'Neil SP, McClure HM, Staprans SI, Feinberg MB. 2003. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18(3):441-452.
119. Simon MA, Brodie SJ, Sasseville VG, Chalifoux LV, Desrosiers RC, Ringler DJ. 1994. Immunopathogenesis of SIVmac. Virus Res 32(2):227-251.
120. Smith SM, Makuwa M, Lee F, Gettie A, Russo C, Marx PA. 1998. Sivrcm infection of macaques. J Med Primatol 27(2-3):94-98.
121. Snider TG III, Coats KS, Storts RW, Graves KF, Cooper CR, Hoyt PG, Luther DG, Jenny BF. 2003. Natural bovine lentivirus type 1 infection in holstein dairy cattle. II. Lymphoid tissue lesions. Comp lmmunol Microbiol Infect Dis 26(1):1-15.
122. St-Louis MC, Cojocariu M, Archambault D. 2004. The molecular biology of bovine immunodeficiency virus: a comparison with other lentiviruses. Anim Health Res Rev 5(2):125-143.
123. Stoddart CA, Geleziunas R, Ferrell S, Linquist-Stepps V, Moreno ME, Bare C, Xu W, Yonemoto W, Bresnahan PA, McCune JM, Greene WC. 2003. Human immunodeficiency virus type 1 nef-mediated downregulation of CD4 correlates with nef enhancement of viral pathogenesis. J Virol 77(3):2124-2133.
124. Sullivan PS, McDonald TP. 1995. Evaluation of murine leukemia virus infection as a model for thrombocytopenia of HIV/AIDS: Mechanism of thrombocytopenia and modulation of thrombocytopenia by thrombopoietin. AIDS Res Hum Retroviruses 11(7):837-842.
125. Takehisa J, Harada Y, Ndembi N, Mboudjeka I, Taniguchi Y, Ngansop C, Kuate S, Zekeng L, Ibuki K, Shimada T, Bikandou B, Yamaguchi-Kabata Y, Miura T, Ikeda M, Ichimura H, Kaptue L, Hayami M. 2001. Natural infection of wild-born mandrills (mandrillus sphinx) with two different types of simian immunodeficiency virus. AIDS Res Hum Retroviruses 17(12):1143-1154.
126. Terwee JA, Yactor JK, Sondgeroth KS, Vandewoude S. 2005. Puma lentivirus is controlled in domestic cats after mucosal exposure in the absence of conventional indicators of immunity. J Virol 79(5):2797-2806.
127. Thormar H. 2005. Maedi-visna virus and its relationship to human immunodeficiency virus. AIDS Rev 7(4):233-245.
128. Tindall B, Cooper DA, Donovan B, Penny R. 1988. Primary human immunodeficiency virus infection. Clinical and serologic aspects. Infect Dis Clin North Am 2(2):329-341.
129. Tompkins MB, Nelson PD, English RV, Novotney C. 1991. Early events in the immunopathogenesis of feline retrovirus infections. J Am Vet Med Assoc 199(10):1311-1315.
130. Torres AN, Mathiason CK, Hoover EA. 2005. Re-examination of feline leukemia virus: host relationships using real-time PCR. Virology 332(1):272-283.
131. Tristem M, Marshall C, Karpas A, Hill F. 1992. Evolution of the primate lentiviruses: evidence from VPX and VPR. Embo J 11(9):3405-3412.
132. Troyer JL, Pecon-Slattery J, Roelke ME, Black L, Packer C, O'Brien SJ. 2004. Patterns of feline immunodeficiency virus multiple infection and genome divergence in a free-ranging population of African lions. J Virol 78(7):3777-3791.
133. Troyer JL, Pecon-Slattery J, Roelke ME, Johnson W, VandeWoude S, Vazquez-Salat N, Brown M, Frank L, Woodroffe R, Winterbach C, Winterbach H, Hemson G, Bush M, Alexander KA, Revilla E, O'Brien SJ. 2005. Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus among felidae and hyaenidae species. J Virol 79(13):8282-8294.
134. VandeBerg JL. 2003. International perspectives: the future of non-human primate resources. International Perspectives: the future of nonhuman prima te resources; Washington DC. National Academies Press.
135. VandeWoude S, Apetrei C. 2006. Going wild: lessons from T-lymphotropic naturally occurring lentiviruses. Clin Microbiol Rev 19(4):728-762.
136. VandeWoude S, Hageman CA, O'Brien SJ, Hoover EA. 2002. Nonpathogenic lion and puma lentiviruses impart resistance to superinfection by virulent feline immunodeficiency virus. J Acquir Immune Defic Syndr 29(1):1-10.
137. VandeWoude S, Hageman CL, Hoover EA. 2003. Domestic cats infected with lion or puma lentivirus develop anti-feline immunodeficiency virus immune responses. J Acquir Immune Defic Syndr 34(1):20-31.
138. VandeWoude S, O'Brien SJ, Hoover EA. 1997. Infectivity of lion and puma lentiviruses for domestic cats. J Gen Virol 78(Pt 4):795-800.
139. Villet S, Bouzar BA, Morin T, Verdier G, Legras C, Chebloune Y. 2003. Maedi-visna virus and caprine arthritis encephalitis virus genomes encode a vpr-like but no tat protein. J Virol 77(17):9632-9638.
140. Villet S, Faure C, Bouzar BA, Morin T, Verdier G, Chebloune Y, Legras C. 2003. Lack of trans-activation function for maedi visna virus and caprine arthritis encephalitis virus tat proteins. Virology 307(2):317-327.
141. Wilcox GE, Chadwick BJ, Kertayadnya G. 1995. Recent advances in the understanding of jembrana disease. Vet Microbiol 46(1-3):249-255.
142. Willett BJ, McMonagle EL, Ridha S, Hosie MJ. 2006. Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus. J Virol 80(7):3386-3394.
143. Wyatt CM, Klotman PE. 2006. Hiv-associated nephropathy: a case study in race and genetics. Am J Kidney Dis 47(6):1084-1085; author reply 1085.
144. Yamamoto JK, Sparger E, Ho EW, Andersen PR, O'Connor TP, Mandell CP, Lowenstine L, Munn R, Pedersen NC. 1988. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res 49(8):1246-1258.
145. Yoshida M, Miyoshi I, Hinuma Y. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 79(6):2031-2035.